From: A two-stage genome-wide association study identifies novel germline genetic variations in CACNA2D3 associated with radiotherapy response in nasopharyngeal carcinoma
Characteristics
rs11130424
P value
OR (95%CI)
Discovery stage
8.71×10-6
2.53 (1.68-3.81)
Validation stage 1
0.046
1.26 (1.00-1.59)
Validation stage 2
1.33×10-4
2.33 (1.51-3.62)
Combined stage
1.38×10-5
1.70 (1.34-2.15)